pubmed.ncbi.nlm.nih.gov

Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro - PubMed

Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro

Andrea Schlöbe et al. Urol Res. 2003 Feb.

Abstract

Staphylococcal infections are a common and severe complication after the implantation of a prosthesis. We developed an in-vitro model for biomaterial-associated infections and studied the effects of human recombinant granulocyte colony-stimulating factor (rhuG-CSF; filgrastime) on the eradication of bacteria from the surface of biomaterial. Latex beads (25 micro m) were incubated with 10(7) colony forming units of either a slime producing (DSM 3269) or non-slime producing strain (ATCC 14990) of Staphylococcus epidermidis. Infected particles were consecutively confronted with effector cells, derived from heparinized whole blood samples taken from healthy volunteers, after stimulation with rhuG-CSF (5,000 IU/ml, 10,000 IU/ml). Control blood specimens were not stimulated or conditioned with normal saline. The results indicate that stimulation with rhuG-CSF induced an increased rate of phagocytosis and lead to a more rapid reduction of adhering bacteria from the surface of the beads. Therefore, the in-vitro data suggest that patients with prosthesis infection may profit from an additional treatment with rhuG-CSF.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Infect Dis. 1991 Mar;163(3):579-83 - PubMed
    1. Infect Immun. 1999 May;67(5):2627-32 - PubMed
    1. Biomaterials. 1993 Sep;14(11):845-53 - PubMed
    1. J Surg Res. 1997 May;69(2):372-8 - PubMed
    1. Infect Immun. 1997 Apr;65(4):1522-6 - PubMed

MeSH terms

Substances

LinkOut - more resources